因此，现在有七种很被看好的抗肺结核药物正处于临床试验阶段，还有大约20多种药物处于研究阶段。
As a result, seven potential anti-TB drugs are now in clinical trials and around 20 more are under investigation.
肺结核是一种风媒传播的疾病并且依然有7%的致病率。几乎一半的病人有多种药物的耐药现象发生并导致死亡。
TB is an airborne infection which still proves fatal in about 7% of cases. Almost half of patients with the multi-drug resistant form of the disease die.
而最重要的，莫过于是多耐药结核病例增加，病人肺内的结核菌对多种抗结核药物发生耐药。
And most important, is a multi-drug-resistant TB cases increased, the pulmonary tuberculosis patients a wide range of anti-tuberculosis drug resistance occurred.
而最重要的，莫过于是多耐药结核病例增加，病人肺内的结核菌对多种抗结核药物发生耐药。
And most important, is a multi-drug-resistant TB cases increased, the pulmonary tuberculosis patients a wide range of anti-tuberculosis drug resistance occurred.
应用推荐